Dengue Clinical Trial
Official title:
Pharmacological Effect of Carica Folia Mother Tincture in Healthy Individual's Blood Parameter.
AIMS & OBJECTIVES To evaluate the effectiveness of administering of Carica folia mother
tincture to healthy individual's Platelet count.
Sample Details:- Students, Doctors and non-teaching staffs of Father Muller Homoeopathic
Medical College are taken up for the study. A minimum of 60 persons will be selected and
will be divided into two groups, Control & Experiment by lottery method.
Voluntary participation in the study is expected. 30 persons in each group. One group will
receive Carica folia mother tincture and other group will receive placebo.
Complete Blood count including platelet count will be measured for all 60 subjects before
commencing the study.
The drug namely Carica Folia mother tincture will be procured from Father Muller
Homoeopathic Pharmaceutical Division which compiles with the standards of Homoeopathic
Pharmacopeia of India.
Daily dosage -30 drops of Carica Folia mother tincture in 30 ml of distilled water morning
and night for 3days.
On 4th day complete blood count including platelet count will be estimated for all 60
subjects.
Research Methodology and Statistics:
Pre &Post with Control Design is done. Data from the sample is collected and is subjected to
Paired 't' test and unpaired 't' test.
HYPOTHESIS:-
Null hypothesis:
No significant changes in complete blood count and platelet count before and after the
intervention.
Alternate hypothesis:
There is significant variation in complete blood count and platelet count before and the
intervention.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05321264 -
Educational Intervention to Promote Control Behaviors and Prevention of Dengue
|
N/A | |
| Completed |
NCT01436396 -
Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
|
Phase 3 | |
| Completed |
NCT01391819 -
Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children
|
N/A | |
| Completed |
NCT03641339 -
Defining Skin Immunity of a Bite of Key Insect Vectors in Humans
|
N/A | |
| Completed |
NCT02833584 -
Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults
|
N/A | |
| Completed |
NCT02433652 -
Evaluating the Safety and Protective Efficacy of a Single Dose of a Trivalent Live Attenuated Dengue Vaccine to Protect Against Infection With DENV-2
|
Phase 1 | |
| Completed |
NCT01477671 -
Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
|
N/A | |
| Recruiting |
NCT00377754 -
Prospective Study of Infant Dengue
|
N/A | |
| Recruiting |
NCT05919277 -
A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires
|
||
| Recruiting |
NCT04582474 -
Demonstration of an Electronic Clinical Decision Support Module for Dengue in Burkina Faso
|
N/A | |
| Completed |
NCT01983553 -
Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
|
||
| Completed |
NCT03803618 -
Dengue Effectiveness Study in the Philippines
|
||
| Active, not recruiting |
NCT05967455 -
Homologous Re-infection With Dengue 1 or Dengue 3
|
Phase 1 | |
| Completed |
NCT03631719 -
Impact of Wolbachia Deployment on Arboviral Disease Incidence in Medellin and Bello, Colombia
|
||
| Recruiting |
NCT02606019 -
The Use of Biomarkers in Predicting Dengue Outcome
|
N/A | |
| Completed |
NCT02372175 -
Assessment of a Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) Virus Strain
|
Phase 1 | |
| Active, not recruiting |
NCT01696422 -
Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine
|
Phase 2 | |
| Completed |
NCT00993447 -
Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America
|
Phase 2 | |
| Completed |
NCT00375726 -
Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3/4delta30[ME]) in Healthy Adults
|
Phase 1 | |
| Completed |
NCT05153018 -
Population Immunity AgaiNst mosquitO-borne Diseases in Vanuatu
|
N/A |